Hemophilia A - Pipeline Review, H2 2012 New Report
Hemophilia A - Pipeline Review, H2 2012, provides an overview of the Hemophilia A therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia A, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hemophilia A. 'Hemophilia A - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured...
View full press release